Built to make gut biology
measurable
Foli Bio is building a new molecular data layer for gut biology through stool-derived host RNA — enabling non-invasive transcriptomic readouts for translational studies, clinical diagnostics, and precision medicine.
Making the gut transcriptome accessible
The gastrointestinal tract is central to mucosal immunity, barrier function, metabolism, gastrointestinal cancer biology, and therapeutic response — but local gut biology is difficult to measure repeatedly without invasive procedures.
Biopsy is episodic. Blood misses local gut signals. Microbiome sequencing captures microbial composition, not the human host response.
Foli Bio is building Foli-seq™ to make host gut transcriptomics accessible through stool-derived RNA, enabling longitudinal molecular readouts for translational studies, biomarker discovery, clinical diagnostics, and precision medicine.
The Gut RNA Atlas — a data platform mapping host molecular signals across gut biology and disease.
A multidisciplinary team built around gut biology
Foli Bio brings together expertise in host transcriptomics, gut biology, assay development, bioinformatics, and translational partnerships to advance stool-derived host RNA into real-world research and diagnostic applications.
Leads Foli Bio’s platform strategy, translational partnerships, and development of stool-derived host transcriptomic technologies.
Leads assay development, laboratory workflows, and translational study execution across Foli-seq™ programs.
Supports partnership development, customer engagement, and commercial strategy across pharma, biotech, and translational research programs.
Supports NGS data processing, biomarker identification, transcriptomic data analysis, and computational workflows across Foli-seq™ studies.
Supports NGS data processing, biomarker identification, transcriptomic data analysis, and computational workflows across Foli-seq™ studies.
Supports laboratory workflows, sample processing, and experimental execution for stool-derived host RNA profiling.
Founded by experts across gut biology and functional genomics
Foli Bio was co-founded with scientific leaders across systems biology, genome engineering, gastroenterology, mucosal immunology, and translational medicine.
Professor, Columbia University
Backed by a growing research and innovation ecosystem
Foli Bio is supported by scientific institutions, grant programs, venture partners, and translational research collaborators.
To discuss translational research partnerships or platform collaborations, please contact us directly.
Partner with us to make gut biology measurable
We work with research, clinical, and industry partners applying non-invasive host gut transcriptomics to translational studies, biomarker discovery, clinical diagnostics, and precision medicine.